Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Other Long Term Assets : $0.00 Mil (As of Apr. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Advanced Proteome Therapeutics Other Long Term Assets?

Advanced Proteome Therapeutics's other long-term assets for the quarter that ended in Apr. 2023 was $0.00 Mil.

Advanced Proteome Therapeutics's quarterly other long-term assets stayed the same from Oct. 2022 ($0.00 Mil) to Jan. 2023 ($0.00 Mil) and stayed the same from Jan. 2023 ($0.00 Mil) to Apr. 2023 ($0.00 Mil).

Advanced Proteome Therapeutics's annual other long-term assets increased from Jul. 2020 ($-0.00 Mil) to Jul. 2021 ($0.00 Mil) but then declined from Jul. 2021 ($0.00 Mil) to Jul. 2022 ($-0.00 Mil).

Advanced Proteome Therapeutics Other Long Term Assets Historical Data

The historical data trend for Advanced Proteome Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Proteome Therapeutics Other Long Term Assets Chart

Advanced Proteome Therapeutics Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Other Long Term Assets

Get a 7-Day Free Trial

Advanced Proteome Therapeutics Quarterly Data
	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23
Other Long Term Assets	Get a 7-Day Free Trial															-	-	-	-	-

Advanced Proteome Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advanced Proteome Therapeutics Corp (OTCPK:APTCF) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

0E81:Germany APC.H:Canada

Address

8337 Eastlake Drive, Suite 104, Burnaby, BC, CAN, V5A 4W2

Website

https://www.advancedproteome.com

Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Headlines

From GuruFocus

Advanced Proteome Therapeutics Announces Appointment of Bill Dickie as Chief Executive Officer, President and Director

By GlobeNewswire GlobeNewswire • 06-06-2018

Advanced Proteome Therapeutics Announces Closing of First Tranche of a Non-Brokered Private Placement

By GlobeNewswire GlobeNewswire • 08-23-2018